Cullgen Announces Additions to Board of Directors and Scientific Advisory Board

SAN DIEGO–(BUSINESS WIRE)–Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced the addition of Xiaogang Pan, PhD to its Board of Directors, and Ian Storer, PhD to its Scientific Advisory Board. Pan Xiaogang, currently Managing Director…
Click here to view original post